Literature DB >> 23661497

Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis.

Jennifer E Snyder-Cappione1, Douglas F Nixon, Joyce C Chi, Michelle-Linh T Nguyen, Christopher K Kirby, Jeffrey M Milush, Laura L Koth.   

Abstract

Invariant natural killer T (iNKT) cells are integral components of immune responses during many chronic diseases, yet their surface phenotypes, subset distribution, and polyfunctional capacity in this environment are largely unknown. Therefore, using flow cytometry, we determined iNKT cell phenotypic and functional characteristics in subjects with chronic inflammatory disease sarcoidosis and matched controls. We found that sarcoidosis subjects displayed lower iNKT-cell frequencies, which correlated with lung fibrosis, C-reactive protein levels, and other measures of clinical disease. The CD4(-) CD8(-) (double negative, DN) iNKT-cell population was selectively lower in diseased individuals and the remaining DN iNKT cells exhibited higher frequencies of the activation markers CD69 and CD56. Functionally, both total IFN-γ(+) and the dual-functional IFN-γ(+) TNF-α(+) iNKT cells were decreased in sarcoidosis subjects and these functional defects correlated with total iNKT-cell circulating frequencies. As the loss of polyfunctionality can reflect functional exhaustion, we measured the surface antigens programmed death-1 receptor and CD57 and found that levels inversely correlated with dual-functional iNKT-cell percentages. These findings reveal that, similar to traditional T cells, iNKT cells may also undergo functional exhaustion, and that circulating iNKT-cell frequencies reflect these defects. Programmed death-1 receptor antagonists may therefore be attractive therapeutic candidates for sarcoidosis and other iNKT-cell-mediated chronic diseases.
© 2013 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Flow cytometry; Inflammation; Interferon-gamma (IFN-γ); Invariant natural killer T (iNKT) cells; Sarcoidosis

Mesh:

Substances:

Year:  2013        PMID: 23661497      PMCID: PMC3869389          DOI: 10.1002/eji.201243185

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  61 in total

1.  Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection.

Authors:  Seung-Jung Kee; Yong-Soo Kwon; Yong-Wook Park; Young-Nan Cho; Sung-Ji Lee; Tae-Jong Kim; Shin-Seok Lee; Hee-Chang Jang; Myung-Geun Shin; Jong-Hee Shin; Soon-Pal Suh; Dong-Wook Ryang
Journal:  Infect Immun       Date:  2012-03-12       Impact factor: 3.441

Review 2.  Sarcoidosis.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki; Alvin S Teirstein
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

3.  Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals.

Authors:  Aaron J Tyznik; Emmanuel Tupin; Niranjana A Nagarajan; Min J Her; Chris A Benedict; Mitchell Kronenberg
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 4.  Targeting natural killer cells and natural killer T cells in cancer.

Authors:  Eric Vivier; Sophie Ugolini; Didier Blaise; Christian Chabannon; Laurent Brossay
Journal:  Nat Rev Immunol       Date:  2012-03-22       Impact factor: 53.106

5.  Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis.

Authors:  Ling-Pei Ho; Britta C Urban; David R Thickett; Robert J O Davies; Andrew J McMichael
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

6.  Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment.

Authors:  Johan K Sandberg; Nina Bhardwaj; Douglas F Nixon
Journal:  Eur J Immunol       Date:  2003-03       Impact factor: 5.532

7.  Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy.

Authors:  Woo-Sung Chang; Ji-Yeon Kim; Yeon-Jeong Kim; Yun-Sun Kim; Jung-Mi Lee; Miyuki Azuma; Hideo Yagita; Chang-Yuil Kang
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in males.

Authors:  Jennifer E Snyder-Cappione; Camilla Tincati; Ijeoma G Eccles-James; Amedeo J Cappione; Lishomwa C Ndhlovu; Laura L Koth; Douglas F Nixon
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

Review 9.  The contrasting roles of NKT cells in tumor immunity.

Authors:  Jay A Berzofsky; Masaki Terabe
Journal:  Curr Mol Med       Date:  2009-08       Impact factor: 2.222

10.  Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection.

Authors:  Michaela Lucas; Stephan Gadola; Ute Meier; Neil T Young; Gillian Harcourt; Anastasios Karadimitris; Nikki Coumi; Dave Brown; Geoff Dusheiko; Vincenzo Cerundolo; Paul Klenerman
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  14 in total

1.  β-glucan in the lymph nodes in sarcoidosis and in Kveim-Siltzbach test reagent.

Authors:  Marjeta Terčelj; Barbara Salobir; Ragnar Rylander
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

2.  IFN-γ-Producing T-Helper 17.1 Cells Are Increased in Sarcoidosis and Are More Prevalent than T-Helper Type 1 Cells.

Authors:  Joris Ramstein; Caroline E Broos; Laura J Simpson; K Mark Ansel; Sara A Sun; Melissa E Ho; Prescott G Woodruff; Nirav R Bhakta; Laura Christian; Christine P Nguyen; Bobby J Antalek; Bryan S Benn; Rudi W Hendriks; Bernt van den Blink; Mirjam Kool; Laura L Koth
Journal:  Am J Respir Crit Care Med       Date:  2016-06-01       Impact factor: 21.405

3.  Invariant natural killer T (iNKT) cells in HAART-treated, HIV-positive patients with bone and cardiovascular impairment.

Authors:  Camilla Tincati; Matteo Basilissi; Elisabetta Sinigaglia; Esther Merlini; Giovanni Carpani; Antonella d'Arminio Monforte; Giulia Marchetti
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

4.  Local and Systemic CD4+ T Cell Exhaustion Reverses with Clinical Resolution of Pulmonary Sarcoidosis.

Authors:  Charlene Hawkins; Guzel Shaginurova; D Auriel Shelton; Jose D Herazo-Maya; Kyra A Oswald-Richter; Joseph E Rotsinger; Anjuli Young; Lindsay J Celada; Naftali Kaminski; Carla Sevin; Wonder P Drake
Journal:  J Immunol Res       Date:  2017-11-06       Impact factor: 4.818

5.  Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging.

Authors:  Anna C Belkina; Alina Starchenko; Katherine A Drake; Elizabeth A Proctor; Riley M F Pihl; Alex Olson; Douglas A Lauffenburger; Nina Lin; Jennifer E Snyder-Cappione
Journal:  Front Immunol       Date:  2018-12-05       Impact factor: 8.786

6.  Age-related differences in the clinical features of ocular sarcoidosis.

Authors:  Kei Takayama; Kozo Harimoto; Tomohito Sato; Yutaka Sakurai; Manzo Taguchi; Takayuki Kanda; Masaru Takeuchi
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

7.  Activation of mucosal-associated invariant T cells in the lungs of sarcoidosis patients.

Authors:  Hisayo Matsuyama; Takuma Isshiki; Asako Chiba; Tetsuo Yamaguchi; Goh Murayama; Yoshikiyo Akasaka; Yoshinobu Eishi; Susumu Sakamoto; Sakae Homma; Sachiko Miyake
Journal:  Sci Rep       Date:  2019-09-12       Impact factor: 4.379

8.  Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma.

Authors:  Renée Poels; Esther Drent; Roeland Lameris; Afroditi Katsarou; Maria Themeli; Hans J van der Vliet; Tanja D de Gruijl; Niels W C J van de Donk; Tuna Mutis
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

9.  Abnormalities in iNKT cells are associated with impaired ability of monocytes to produce IL-10 and suppress T-cell proliferation in sarcoidosis.

Authors:  Anjali Crawshaw; Yvonne R Kendrick; Andrew J McMichael; Ling-Pei Ho
Journal:  Eur J Immunol       Date:  2014-05-12       Impact factor: 5.532

10.  Sarcoidosis activates diverse transcriptional programs in bronchoalveolar lavage cells.

Authors:  Sina A Gharib; Anagha Malur; Isham Huizar; Barbara P Barna; Mani S Kavuru; Lynn M Schnapp; Mary Jane Thomassen
Journal:  Respir Res       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.